Connection

ADAM VOGEL to Receptors, Vascular Endothelial Growth Factor

This is a "connection" page, showing publications ADAM VOGEL has written about Receptors, Vascular Endothelial Growth Factor.
  1. Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. Ann Oncol. 2016 07; 27(7):1273-9.
    View in: PubMed
    Score: 0.119
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.